{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:33:53Z","timestamp":1774690433803,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Vo 926\/3-1"],"award-info":[{"award-number":["Vo 926\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021201","name":"European Academy of Dermatology and Venereology","doi-asserted-by":"publisher","award":["RF-2019-43"],"award-info":[{"award-number":["RF-2019-43"]}],"id":[{"id":"10.13039\/501100021201","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.intimp.2023.109903","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T08:04:57Z","timestamp":1677485097000},"page":"109903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Efficacy of topically applied rapamycin-loaded redox-sensitive nanocarriers in a human skin\/T cell co-culture model"],"prefix":"10.1016","volume":"117","author":[{"given":"F.","family":"Rancan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Rajes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sidiropoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Zabihi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Mirastschijski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"R\u00fchl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Haag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Blume-Peytavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2023.109903_b0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/toxins13050347","article-title":"Macrolides: from toxins to therapeutics","volume":"13","author":"Lenz","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.intimp.2023.109903_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.665647","article-title":"Recent updates on the involvement of PI3K\/AKT\/mTOR molecular cascade in the pathogenesis of hyperproliferative skin disorders","volume":"8","author":"Mercurio","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2023.109903_b0015","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3389\/fimmu.2018.02786","article-title":"Epidermal mTORC1 signaling contributes to the pathogenesis of psoriasis and could serve as a therapeutic target","volume":"9","author":"Buerger","year":"2018","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.intimp.2023.109903_b0020","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3390\/cells11182847","article-title":"mTORC1 Activity in Psoriatic Lesions Is Mediated by Aberrant Regulation through the Tuberous Sclerosis Complex","volume":"11","author":"Ferreri","year":"2022","journal-title":"Cells"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.109903_b0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(00)00617-7","article-title":"Solubilization of rapamycin","volume":"213","author":"Simamora","year":"2001","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.intimp.2023.109903_b0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10717540802481307","article-title":"New approach for local delivery of rapamycin by bioadhesive PLGA-carbopol nanoparticles","volume":"16","author":"Zou","year":"2009","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.intimp.2023.109903_b0035","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2133.2005.06438.x","article-title":"Treatment of psoriasis with topical sirolimus: preclinical development and a randomized, double-blind trial","volume":"152","author":"Ormerod","year":"2005","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.intimp.2023.109903_b0040","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1039\/C9TB00912D","article-title":"Transdermal delivery of rapamycin with poor water-solubility by dissolving polymeric microneedles for anti-angiogenesis","volume":"8","author":"Mao","year":"2020","journal-title":"J. Mater. Chem. B"},{"issue":"6","key":"10.1016\/j.intimp.2023.109903_b0045","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1021\/acsbiomaterials.0c01771","article-title":"Oxidation-sensitive core\u2013multishell nanocarriers for the controlled delivery of hydrophobic drugs","volume":"7","author":"Rajes","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"1","key":"10.1016\/j.intimp.2023.109903_b0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/pharmaceutics13010037","article-title":"Redox-responsive nanocarrier for controlled release of drugs in inflammatory skin diseases","volume":"13","author":"Rajes","year":"2020","journal-title":"Pharmaceutics"},{"issue":"18","key":"10.1016\/j.intimp.2023.109903_b0055","doi-asserted-by":"crossref","first-page":"12213","DOI":"10.1021\/acsomega.1c01058","article-title":"Improved skin permeability after topical treatment with serine protease: probing the penetration of rapamycin by scanning transmission X-ray microscopy","volume":"6","author":"Germer","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.intimp.2023.109903_b0060","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.2147\/IJN.S330716","article-title":"Topical Delivery of Rapamycin by Means of Microenvironment-Sensitive Core-Multi-Shell Nanocarriers: Assessment of Anti-Inflammatory Activity in an ex vivo Skin\/T Cell Co-Culture Model","volume":"16","author":"Rancan","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.intimp.2023.109903_b0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/eji.201545886","article-title":"mTORC1 signaling and IL-17 expression: Defining pathways and possible therapeutic targets","volume":"46","author":"Ren","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2023.109903_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102435","article-title":"Selective targeting of PI3K\u03b4 suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases","volume":"111","author":"Chen","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2023.109903_b0075","series-title":"Sirolimus: its discovery, biological properties, and mechanism of action","first-page":"S7","author":"Sehgal","year":"2003"},{"issue":"6","key":"10.1016\/j.intimp.2023.109903_b0080","first-page":"C1429","article-title":"Proteinase-activated receptors: novel mechanisms of signaling by serine proteases","volume":"274","author":"D\u00e9ry","year":"1998","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"6","key":"10.1016\/j.intimp.2023.109903_b0085","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1468-2494.2011.00671.x","article-title":"Increased mass levels of certain serine proteases in the stratum corneum in acute eczematous atopic skin","volume":"33","author":"Voegeli","year":"2011","journal-title":"Int. J. Cosmet. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2023.109903_b0090","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1365-2133.2006.07743.x","article-title":"Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy","volume":"156","author":"Komatsu","year":"2007","journal-title":"Br. J. Dermatol."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2023.109903_b0095","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1515\/zpch-2017-1048","article-title":"Protease-mediated inflammation: an in vitro human keratinocyte-based screening tool for anti-inflammatory drug nanocarrier systems","volume":"232","author":"Frombach","year":"2018","journal-title":"Z. Phys. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2023.109903_b0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s004030050473","article-title":"The antipsoriatic activity of IL-10 is rather caused by effects on peripheral blood cells than by a direct effect on human keratinocytes","volume":"292","author":"Seifert","year":"2000","journal-title":"Arch. Dermatol. Res."},{"issue":"13","key":"10.1016\/j.intimp.2023.109903_b0105","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.3390\/molecules27134264","article-title":"Modulatory Effect of Diosmin and Diosmetin on Metalloproteinase Activity and Inflammatory Mediators in Human Skin Fibroblasts Treated with Lipopolysaccharide","volume":"27","author":"Feldo","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.intimp.2023.109903_b0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.0906-6705.2004.00159.x","article-title":"Trypsin induces epidermal proliferation and inflammation in murine skin","volume":"13","author":"Meyer-Hoffert","year":"2004","journal-title":"Exp. Dermatol."},{"issue":"7","key":"10.1016\/j.intimp.2023.109903_b0115","first-page":"743","article-title":"Differential regulation of human keratinocyte growth and differentiation by a novel family of protease-activated receptors, Cell Growth and Differentiation-Publication American Association for","volume":"8","author":"Derian","year":"1997","journal-title":"Cancer Res."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2023.109903_b0120","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molimm.2010.07.014","article-title":"Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes","volume":"48","author":"Zhao","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2023.109903_b0125","doi-asserted-by":"crossref","unstructured":"S. Li, R. Thangapazham, J.-a. Wang, S. Rajesh, J. Moss, T.N. Darling, Rapamycin inhibits epidermal cell proliferation in a xenograft model of tuberous sclerosis skin tumors, Cancer Research 70(8_Supplement) (2010) 2501-2501.","DOI":"10.1158\/1538-7445.AM10-2501"},{"issue":"3","key":"10.1016\/j.intimp.2023.109903_b0130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/exd.13882","article-title":"Targeting mTORC 1\/2 with OSI-027 inhibits proliferation and migration of keloid keratinocytes","volume":"28","author":"Chen","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2023.109903_b0135","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3389\/fimmu.2019.01285","article-title":"Mammalian target of Rapamycin (mTOR) and the proteasome attenuates IL-1\u03b2 expression in primary mouse cardiac fibroblasts","volume":"10","author":"Torp","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.109903_b0140","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/0194599815573708","article-title":"Rapamycin inhibits human laryngotracheal stenosis\u2013derived fibroblast proliferation, metabolism, and function in vitro","volume":"152","author":"Namba","year":"2015","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"1","key":"10.1016\/j.intimp.2023.109903_b0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/wrr.12759","article-title":"Activation of mTORC1 in fibroblasts accelerates wound healing and induces fibrosis in mice","volume":"28","author":"Hu","year":"2020","journal-title":"Wound Repair Regen."},{"issue":"9","key":"10.1016\/j.intimp.2023.109903_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12090862","article-title":"Serine Protease-Mediated Cutaneous Inflammation: Characterization of an Ex Vivo Skin Model for the Assessment of Dexamethasone-Loaded Core Multishell-Nanocarriers","volume":"12","author":"Frombach","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2023.109903_b0155","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2017.10.033","article-title":"Topically applied virus-like particles containing HIV-1 Pr55gag protein reach skin antigen-presenting cells after mild skin barrier disruption","volume":"268","author":"Rancan","year":"2017","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.intimp.2023.109903_b0160","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/jid.2008.356","article-title":"Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice","volume":"129","author":"Mahe","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109903_b0165","first-page":"7409420","article-title":"High-throughput screening of potential skin penetration-enhancers using stratum corneum lipid liposomes: preliminary evaluation for different concentrations of ethanol","volume":"2017","author":"Sakdiset","year":"2017","journal-title":"J. Pharm.(Cairo)"},{"issue":"13","key":"10.1016\/j.intimp.2023.109903_b0170","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1084\/jem.20091527","article-title":"External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers","volume":"206","author":"Kubo","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.109903_b0175","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2019.02.028","article-title":"Core-multishell nanocarriers enhance drug penetration and reach keratinocytes and antigen-presenting cells in intact human skin","volume":"299","author":"Frombach","year":"2019","journal-title":"J. Control. Release"},{"issue":"15","key":"10.1016\/j.intimp.2023.109903_b0180","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.3390\/ijms22157970","article-title":"Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies","volume":"22","author":"Suuring","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109903_b0185","doi-asserted-by":"crossref","unstructured":"T. Weichhart, M. S\u00e4emann, The PI3K\/Akt\/mTOR pathway in innate immune cells: emerging therapeutic applications, Annals of the rheumatic diseases 67(Suppl 3) (2008) iii70-iii74.","DOI":"10.1136\/ard.2008.098459"},{"issue":"4","key":"10.1016\/j.intimp.2023.109903_b0190","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.immuni.2008.08.012","article-title":"The TSC-mTOR signaling pathway regulates the innate inflammatory response","volume":"29","author":"Weichhart","year":"2008","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2023.109903_b0195","first-page":"1084","article-title":"Rapamycin inhibits macropinocytosis and mannose receptor\u2013mediated endocytosis by bone marrow\u2013derived dendritic cells","volume":"100","author":"Hackstein","year":"2002","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"7","key":"10.1016\/j.intimp.2023.109903_b0200","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.4049\/jimmunol.181.7.4770","article-title":"Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation","volume":"181","author":"Reichardt","year":"2008","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2023.109903_b0205","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2340\/00015555-2724","article-title":"Blocking mTOR Signalling with Rapamycin Ameliorates Imiquimod-induced Psoriasis in Mice","volume":"97","author":"B\u00fcrger","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.intimp.2023.109903_b0210","doi-asserted-by":"crossref","unstructured":"A.Y. Choo, S.-O. Yoon, S.G. Kim, P.P. Roux, J. Blenis, Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation, Proceedings of the National Academy of Sciences 105(45) (2008) 17414-17419.","DOI":"10.1073\/pnas.0809136105"},{"issue":"4","key":"10.1016\/j.intimp.2023.109903_b0215","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/ajd.13671","article-title":"Systematic review of sirolimus in dermatological conditions","volume":"62","author":"Swarbrick","year":"2021","journal-title":"Australas. J. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109903_b0220","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jdermsci.2014.08.002","article-title":"Vertical inhibition of PI3K\/Akt\/mTOR signaling demonstrates in vitro and in vivo anti-fibrotic activity","volume":"76","author":"Liang","year":"2014","journal-title":"J. Dermatol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2023.109903_b0225","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3390\/biomedicines10040826","article-title":"Efficacy and Safety of Topical Mechanistic Target of Rapamycin Inhibitors for Facial Angiofibromas in Patients with Tuberous Sclerosis Complex: A Systematic Review and Network Meta-Analysis","volume":"10","author":"Lin","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2023.109903_b0230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2016.04.003","article-title":"Topical use of mammalian target of rapamycin (mTOR) inhibitors in tuberous sclerosis complex\u2014a comprehensive review of the literature","volume":"61","author":"J\u00f3\u017awiak","year":"2016","journal-title":"Pediatr. Neurol."},{"issue":"8","key":"10.1016\/j.intimp.2023.109903_b0235","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.3390\/ijms22083968","article-title":"Rapamycin Alleviates 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin-Induced Aggravated Dermatitis in Mice with Imiquimod-Induced Psoriasis-Like Dermatitis by Inducing Autophagy","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2023.109903_b0240","doi-asserted-by":"crossref","first-page":"534","DOI":"10.5021\/ad.2020.32.6.534","article-title":"Successful amelioration of inflammatory linear verrucous epidermal nevus with topical sirolimus","volume":"32","author":"Patel","year":"2020","journal-title":"Ann. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109903_b0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00403-012-1288-3","article-title":"Visible effects of rapamycin (sirolimus) on human skin explants in vitro","volume":"305","author":"Peramo","year":"2013","journal-title":"Arch. Dermatol. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:51:25Z","timestamp":1761587485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923002230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":49,"alternative-id":["S1567576923002230"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109903","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of topically applied rapamycin-loaded redox-sensitive nanocarriers in a human skin\/T cell co-culture model","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109903"}}